Isolation of Live Myeloid and Epithelial Cell Populations from the Mouse Lung
January 31st, 2025
2.4K views
This protocol details the isolation of live immune and non-immune populations from the mouse lung at a steady state and following influenza infection. It also provides gating strategies for identifying epithelial and myeloid cell subsets.
Overview
This protocol details the isolation of live immune and non-immune populations from the mouse lung at steady state and following influenza infection. It provides gating strategies for identifying epithelial and myeloid cell subsets.
Key Study Components
Area of Science
- Neuroscience
- Immunology
- Cell Biology
Background
- The study focuses on lung repair mechanisms after viral infection.
- Understanding the role of immune cells in epithelial repair is crucial.
- Research addresses the challenges of isolating viable cells from different lung compartments.
- Investigates the interactions between immune and epithelial cells in the respiratory tract.
Purpose of Study
- To isolate viable immune and non-immune cells from mouse lungs.
- To develop a gating strategy for identifying specific cell subsets.
- To explore the impact of viral injury and repair on future disease pathologies.
Methods Used
- Isolation of live immune and non-immune populations from mouse lung.
- Gating strategies for identifying epithelial and myeloid cell subsets.
- Analysis of lung repair mechanisms post-influenza infection.
- Assessment of crosstalk between immune and epithelial cells.
Main Results
- Successful isolation of distinct immune and non-immune cell populations.
- Identification of specific epithelial and macrophage subsets.
- Insights into the mechanisms of lung repair following viral infection.
- Contribution to understanding future disease pathologies related to lung injury.
Conclusions
- The protocol enhances the ability to study lung immune responses.
- It provides valuable tools for investigating epithelial repair mechanisms.
- Findings may inform future research on respiratory diseases.
Frequently Asked Questions
What is the main focus of this study?
The study focuses on lung repair mechanisms after viral infection and the role of immune cells in this process.
What types of cells are isolated in this protocol?
The protocol isolates both immune and non-immune populations from the mouse lung.
How does this research contribute to the field?
It provides insights into the crosstalk between immune and epithelial cells, which is crucial for understanding lung repair and disease.
What methods are used for cell isolation?
The protocol details specific gating strategies for identifying epithelial and myeloid cell subsets.
Why is it important to study lung repair mechanisms?
Understanding lung repair mechanisms can help inform treatments for respiratory diseases and improve patient outcomes.
Executive Industry Relevance
Simultaneous isolation of live myeloid and epithelial cell populations from mouse lung enables comprehensive interrogation of intercellular crosstalk in respiratory disease models. This capability supports mechanistic de-risking and predictive confidence at the target validation and early discovery stages. The method enhances portfolio decision-making by providing high-quality, multiparametric single-cell suspensions for downstream analysis.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct study of immune-epithelial interactions critical for target validation in lung disease models.
- Supports mechanistic de-risking by allowing functional assessment of both immune and non-immune compartments.
- Facilitates hypothesis-driven interrogation of repair and remodeling pathways post-injury.
Screening & Assay Development
- Provides validated single-cell suspensions suitable for flow cytometry and FACS-based screening workflows.
- Improves assay reproducibility by standardizing cell isolation across immune and epithelial populations.
- Enables quantitative gating strategies for robust identification of cell subsets in both naïve and diseased states.
Translational & Preclinical Research
- Aligns with disease-relevant mouse models for translational biomarker discovery in respiratory research.
- Supports continuity from mechanistic discovery to preclinical validation by enabling analysis of cell-specific responses to infection or injury.
- Reduces biological ambiguity in preclinical models by capturing diverse cell populations in a single workflow.
Pipeline & Workflow Integration
This method integrates at the interface of early discovery and preclinical research, supporting workflows from target validation through lead identification in respiratory disease models.
- Discovery Biology: Enables hypothesis testing on immune-epithelial crosstalk and pathway elucidation in lung repair.
- Screening: Delivers reproducible, quantitative cell subset data for downstream compound or genetic screening.
- Analytics: Provides multiparametric flow cytometry outputs for comparative analysis of disease and control conditions.
- Translational Research: Bridges mechanistic findings to preclinical endpoints in models of infection, allergy, fibrosis, and cancer.
- Enterprise Reuse: Establishes a standardized, scalable protocol adaptable across respiratory research programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in lung disease research.
- Operational Value: Streamlines cell isolation, enhances reproducibility, and supports high-throughput analysis.
- Strategic Value: Improves go/no-go decisions by enabling robust, multiparametric data generation early in the pipeline.
- Portfolio Impact: Supports risk-adjusted prioritization of targets and models for advancement.
Implementation Considerations
- Requires expertise in mouse lung dissection, enzymatic digestion, and flow cytometry analysis.
- Needs access to FACS instrumentation and analytical infrastructure for multiparametric gating.
- Demands cross-team standardization of gating strategies and sample handling protocols.
- Adaptable to various mouse models of respiratory disease, but may require optimization for specific endpoints.
- Cell viability and yield depend on precise execution of enzymatic and mechanical dissociation steps.
Biopharma FAQs
Why does null hypothesis testing matter for immune-epithelial crosstalk studies?
Null hypothesis testing enables objective evaluation of whether observed differences in immune and epithelial cell interactions are statistically significant, supporting rigorous target validation in lung disease models.
How does independent variable isolation fit the lung cell gating workflow?
Isolating both immune and epithelial populations allows controlled assessment of each compartment's contribution to lung repair, clarifying the impact of specific variables in discovery-stage experiments.
What do quantitative dependent variable measurements enable in flow cytometry analysis?
Quantitative measurements of cell subset frequencies and viability provide robust data for comparing naïve and infected states, enabling precise evaluation of disease mechanisms and intervention effects.
Why are replication requirements critical for cross-functional lung cell studies?
Replication ensures that observed cell population changes are reproducible across experiments and teams, supporting reliable cross-functional collaboration and data integration in respiratory research pipelines.
What statistical analysis capabilities are required before implementing multiparametric gating strategies?
Teams must be equipped to perform statistical comparisons of cell subset distributions and viability metrics to validate gating strategies and interpret biological significance in preclinical models.
